These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31324691)

  • 61. Conserved Vδ1 Binding Geometry in a Setting of Locus-Disparate pHLA Recognition by δ/αβ T Cell Receptors (TCRs): Insight into Recognition of HIV Peptides by TCRs.
    Shi Y; Kawana-Tachikawa A; Gao F; Qi J; Liu C; Gao J; Cheng H; Ueno T; Iwamoto A; Gao GF
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
    Lev A; Novak H; Segal D; Reiter Y
    J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.
    Morozov GI; Zhao H; Mage MG; Boyd LF; Jiang J; Dolan MA; Venna R; Norcross MA; McMurtrey CP; Hildebrand W; Schuck P; Natarajan K; Margulies DH
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):E1006-15. PubMed ID: 26869717
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells.
    Saini SK; Tamhane T; Anjanappa R; Saikia A; Ramskov S; Donia M; Svane IM; Jakobsen SN; Garcia-Alai M; Zacharias M; Meijers R; Springer S; Hadrup SR
    Sci Immunol; 2019 Jul; 4(37):. PubMed ID: 31324690
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.
    Matsui K; Boniface JJ; Steffner P; Reay PA; Davis MM
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12862-6. PubMed ID: 7809136
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells.
    Hong J; Persaud SP; Horvath S; Allen PM; Evavold BD; Zhu C
    J Immunol; 2015 Oct; 195(8):3557-64. PubMed ID: 26336148
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
    Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.
    Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
    Nature; 1996 Nov; 384(6605):134-41. PubMed ID: 8906788
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
    Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
    Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex.
    Harris DT; Wang N; Riley TP; Anderson SD; Singh NK; Procko E; Baker BM; Kranz DM
    J Biol Chem; 2016 Nov; 291(47):24566-24578. PubMed ID: 27681597
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules.
    Takeshita T; Kozlowski S; England RD; Brower R; Schneck J; Takahashi H; DeLisi C; Margulies DH; Berzofsky JA
    Int Immunol; 1993 Sep; 5(9):1129-38. PubMed ID: 8241055
    [TBL] [Abstract][Full Text] [Related]  

  • 72. alpha beta T cell receptor ligand-specific oligomerization revisited.
    Baker BM; Wiley DC
    Immunity; 2001 Jun; 14(6):681-92. PubMed ID: 11420039
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Computationally profiling peptide:MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies.
    Raybould MIJ; Nissley DA; Kumar S; Deane CM
    Front Immunol; 2022; 13():1080596. PubMed ID: 36700202
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.
    Gejman RS; Jones HF; Klatt MG; Chang AY; Oh CY; Chandran SS; Korontsvit T; Zakahleva V; Dao T; Klebanoff CA; Scheinberg DA
    Cancer Immunol Res; 2020 May; 8(5):672-684. PubMed ID: 32184297
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Avidity characterization of genetically engineered T-cells with novel and established approaches.
    Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
    BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.
    Inaguma Y; Akahori Y; Murayama Y; Shiraishi K; Tsuzuki-Iba S; Endoh A; Tsujikawa J; Demachi-Okamura A; Hiramatsu K; Saji H; Yamamoto Y; Yamamoto N; Nishimura Y; Takahashi T; Kuzushima K; Emi N; Akatsuka Y
    Gene Ther; 2014 Jun; 21(6):575-84. PubMed ID: 24694533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The contribution of major histocompatibility complex contacts to the affinity and kinetics of T cell receptor binding.
    Zhang H; Lim HS; Knapp B; Deane CM; Aleksic M; Dushek O; van der Merwe PA
    Sci Rep; 2016 Oct; 6():35326. PubMed ID: 27734930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
    Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
    J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
    [TBL] [Abstract][Full Text] [Related]  

  • 79. How an alloreactive T-cell receptor achieves peptide and MHC specificity.
    Wang Y; Singh NK; Spear TT; Hellman LM; Piepenbrink KH; McMahan RH; Rosen HR; Vander Kooi CW; Nishimura MI; Baker BM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4792-E4801. PubMed ID: 28572406
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of the human CD4(+) T-cell repertoire specific for major histocompatibility class I-restricted antigens.
    Legoux F; Gautreau L; Hesnard L; Leger A; Moyon M; Devilder MC; Bonneville M; Saulquin X
    Eur J Immunol; 2013 Dec; 43(12):3244-53. PubMed ID: 23963968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.